Follow
Sverre J Mork
Sverre J Mork
Professor (emeritus) of Pathology, University of Bergen, Norway
Verified email at uib.no
Title
Cited by
Cited by
Year
Axonal transection in the lesions of multiple sclerosis
BD Trapp, J Peterson, RM Ransohoff, R Rudick, S Mörk, L Bö
New England Journal of Medicine 338 (5), 278-285, 1998
50241998
Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions
JW Peterson, L Bö, S Mörk, A Chang, BD Trapp
Annals of Neurology: Official Journal of the American Neurological …, 2001
16912001
Subpial demyelination in the cerebral cortex of multiple sclerosis patients
L Bø, CA Vedeler, HI Nyland, BD Trapp, SJ Mørk
Journal of Neuropathology & Experimental Neurology 62 (7), 723-732, 2003
8552003
Neurological disability correlates with spinal cord axonal loss and reduced N‐acetyl aspartate in chronic multiple sclerosis patients
C Bjartmar, G Kidd, S Mörk, R Rudick, BD Trapp
Annals of neurology 48 (6), 893-901, 2000
7282000
Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration
L Bø, CA Vedeler, H Nyland, BD Trapp, SJ Mørk
Multiple Sclerosis Journal 9 (4), 323-331, 2003
5912003
Ependymoma. A follow‐up study of 101 cases
SJ Mørk, AC Løken
Cancer 40 (2), 907-915, 1977
4591977
Class III β‐tubulin in human development and cancer
CD Katsetos, MM Herman, SJ Mörk
Cell motility and the cytoskeleton 55 (2), 77-96, 2003
3722003
Pathogenesis of tissue injury in MS lesions
BD Trapp, L Bö, S Mörk, A Chang
Journal of neuroimmunology 98 (1), 49-56, 1999
3651999
Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions
L Bö, S Mörk, PA Kong, H Nyland, CA Pardo, BD Trapp
Journal of neuroimmunology 51 (2), 135-146, 1994
3361994
Class III β-tubulin isotype: a key cytoskeletal protein at the crossroads of developmental neurobiology and tumor neuropathology
CD Katsetos, A Legido, E Perentes, SJ Mörk
Journal of child neurology 18 (12), 851-866, 2003
3032003
Oligodendroglioma: incidence and biological behavior in a defined population
SJ Mørk, KF Lindegaard, TB Halvorsen, EH Lehmann, T Solgaard, ...
Journal of neurosurgery 63 (6), 881-889, 1985
2951985
Fish protein hydrolysate reduces plasma total cholesterol, increases the proportion of HDL cholesterol, and lowers acyl-CoA: cholesterol acyltransferase activity in liver of …
H Wergedahl, OA Gudbrandsen, Z Muna, RK Berge, B Liaset, E Lied, ...
The Journal of nutrition 134 (6), 1320-1327, 2004
2922004
Primary intraspinal neoplasms in Norway, 1955 to 1986: a population-based survey of 467 patients
A Helseth, SJ Mørk
Journal of neurosurgery 71 (6), 842-845, 1989
2781989
Expression of oligodendrocyte progenitor cell antigens by gliomas: implications for the histogenesis of brain tumors
Y Shoshan, A Nishiyama, A Chang, S Mörk, GH Barnett, JK Cowell, ...
Proceedings of the National Academy of Sciences 96 (18), 10361-10366, 1999
2351999
Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG
E Ulvestad, K Williams, C Vedeler, J Antel, H Nyland, S Mørk, R Matre
Journal of the neurological sciences 121 (2), 125-131, 1994
2041994
Grey matter pathology in multiple sclerosis
L Bö, JJG Geurts, SJ Mörk, P Van Der Valk
Acta Neurologica Scandinavica 113, 48-50, 2006
1962006
Distribution of immunoglobulin superfamily members ICAM-1,-2,-3, and the β2 integrin LFA-1 in multiple sclerosis lesions
L Bö, JW Peterson, S Mørk, PA Hoffman, WM Gallatin, RM Ransohoff, ...
Journal of Neuropathology & Experimental Neurology 55 (10), 1060-1072, 1996
1881996
Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p …
JM Kros, T Gorlia, MC Kouwenhoven, PP Zheng, VP Collins, ...
Journal of Neuropathology & Experimental Neurology 66 (6), 545-551, 2007
1822007
Neoplasms of the central nervous system in Norway: IV. A population‐based epidemiological study of meningiomas
ARE HELSETH, SJ MØRK, A JOHANSEN, S TRETLI
Apmis 97 (7‐12), 646-654, 1989
157*1989
EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis
KM Talasila, A Soentgerath, P Euskirchen, GV Rosland, J Wang, ...
Acta neuropathologica 125, 683-698, 2013
1522013
The system can't perform the operation now. Try again later.
Articles 1–20